High Flow vs Conventional Oxygen in Head and Neck Surgery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

July 1, 2024

Conditions
Pulmonary DiseaseCOPD
Interventions
DEVICE

HFOT using AIRVO2

The AIRVO 2 is for the treatment of spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases. The subjects in this group will receive HFOT at a flow rate of 60-30L liters per minute, maximum concentration of 40%, which will be titrated by bedside nurse to maintain an oxygen saturation of 92% or greater (unless there is a history of COPD and then the clinician can recommend \>88%)

DEVICE

COT

Subjects will be placed on aerosolized trach mask with cool humidification, and titrated to keep oxygen saturation \>92% (unless there is a history of COPD and then the clinician can recommend \>88%)

Trial Locations (1)

32209

University of Florida, Jacksonville

All Listed Sponsors
collaborator

Fisher and Paykel Healthcare

INDUSTRY

lead

University of Florida

OTHER